Vertex Pharmaceuticals Incorporated (LON:0QZU)
London · Delayed Price · Currency is GBP · Price in USD 451.92
+6.60 (1.48%)
At close: Dec 12, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 85.87 billion as of December 12, 2025. Its market cap has decreased by -10.43% in one year.
Market Cap
85.87B
Enterprise Value
78.25B
Revenue
8.72B
Ranking
n/a
PE Ratio
31.41
Stock Price
451.92
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 85.87B, an increase of 167,580.17%. That is a compound annual growth rate of 24.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 85.87B | 3.66% |
| Dec 31, 2024 | 82.84B | 0.64% |
| Dec 29, 2023 | 82.31B | 33.80% |
| Dec 30, 2022 | 61.52B | 49.20% |
| Dec 31, 2021 | 41.23B | -8.40% |
| Dec 31, 2020 | 45.01B | 5.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.84B |
| GSK plc | 73.12B |
| Haleon | 32.21B |
| Smith & Nephew | 10.30B |
| Convatec Group | 4.47B |
| Hikma Pharmaceuticals | 3.38B |
| Genus | 1.71B |
| HUTCHMED (China) | 1.69B |